RS12210538 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Arachidonoylcarnitine (C20:4) levels | G | OR: 0.47 | 6E-174 | PubMed |
| Dihomo-linolenoylcarnitine (C20:3n3 or 6) levels | G | OR: 0.46 | 2E-164 | PubMed |
| Octadecandienylcarnitine levels | A | OR: 25.6 | 2E-144 | PubMed |
| Acylcarnitine (18:1) levels | G | — | 6E-97 | PubMed |
| Acylcarnitine (18:1) levels | G | OR: 0.49 | 6E-83 | PubMed |
| Acylcarnitine (18:1) levels | G | OR: 0.49 | 4E-82 | PubMed |
| Acylcarnitine (16:0) levels | G | OR: 0.47 | 1E-76 | PubMed |
| Acylcarnitine (16:0) levels | G | OR: 0.47 | 9E-76 | PubMed |
| Dihomo-linoleoylcarnitine (C20:2) levels | G | OR: 0.32 | 4E-72 | PubMed |
| Plasma arachidonoylcarnitine (C20:4) levels in chronic kidney disease | G | OR: 0.3 | 3E-70 | PubMed |
| Acylcarnitine (18:2) levels | G | OR: 0.44 | 9E-68 | PubMed |
| Carnitine C18:2 levels | G | OR: 0.3 | 2E-67 | PubMed |
| Acylcarnitine (18:2) levels | G | OR: 0.44 | 2E-66 | PubMed |
| Linoleoylcarnitine levels | G | OR: 0.29 | 2E-63 | PubMed |
| Acylcarnitine (18:0) levels | G | OR: 0.42 | 3E-62 | PubMed |
| Acylcarnitine (18:0) levels | G | OR: 0.42 | 7E-62 | PubMed |
| Metabolite levels (dihomo-linolenoylcarnitine (C20:3n3 or 6)) | G | OR: 0.57 | 2E-61 | PubMed |
| Acylcarnitine (14:0) levels | G | OR: 0.42 | 3E-61 | PubMed |
| Arachidonoylcarnitine (C20:4) levels | G | OR: 0.44 | 9E-59 | PubMed |
| Metabolite levels (linoleoylcarnitine; linoleoylcarnitine (C18:2); C18:2 carnitine; C18_2_carnitine) | G | OR: 0.3 | 7E-58 | PubMed |